Trial Profile
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pixantrone (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms ALLIANCE
- 06 Apr 2018 Status changed from active, no longer recruiting to completed.
- 13 Jul 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 19 Jun 2012 Actual end date Jan 2012 added as reported by ClinicalTrials.gov.